↓ Skip to main content

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
84 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer
Published in
JAMA Oncology, September 2021
DOI 10.1001/jamaoncol.2021.2318
Pubmed ID
Authors

Heath Skinner, Chen Hu, Theodoros Tsakiridis, Rafael Santana-Davila, Bo Lu, Jeremy J. Erasmus, Anthony J. Doemer, Gregory M. M. Videtic, James Coster, Alex Xuezhong Yang, Richard Y. Lee, Maria Werner-Wasik, Philip E. Schaner, Steven E. McCormack, Benjamin T. Esparaz, Ronald C. McGarry, Jose Bazan, Timothy Struve, Rebecca Paulus, Jeffrey D. Bradley

Twitter Demographics

The data shown below were collected from the profiles of 84 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 11%
Researcher 2 7%
Lecturer 2 7%
Student > Ph. D. Student 2 7%
Student > Doctoral Student 1 4%
Other 2 7%
Unknown 15 56%
Readers by discipline Count As %
Nursing and Health Professions 4 15%
Medicine and Dentistry 4 15%
Unspecified 3 11%
Biochemistry, Genetics and Molecular Biology 2 7%
Sports and Recreations 1 4%
Other 0 0%
Unknown 13 48%

Attention Score in Context

This research output has an Altmetric Attention Score of 106. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#333,676
of 22,788,370 outputs
Outputs from JAMA Oncology
#588
of 2,964 outputs
Outputs of similar age
#8,914
of 426,439 outputs
Outputs of similar age from JAMA Oncology
#17
of 92 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,964 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 82.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.